Skip to content

Effect of 'Teach-back', a simple communication tool, on disease knowledge in people with chronic hepatitis B

Health Literacy and Chronic Hepatitis B: Using teach-­back to improve patient understanding. – a randomized controlled study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000512123
Enrollment
70
Registered
2019-03-29
Start date
2017-02-01
Completion date
2017-05-12
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Limited health literacy has great impact on patient health outcomes; poorer knowledge of disease is linked with suboptimal self-care, reduced treatment adherence and increased use of emergency services. Studies conducted to assess health literacy and patient understanding amongst patients living with chronic hepatitis B (CHB) have revealed gaps in disease-specific knowledge. Despite this, there are few studies evaluating strategies to improve patient knowledge of hepatitis B. The 'teach-back' strategy is a communication tool that has been shown to be successful in improving disease-specific knowledge in other areas of health. 'Teach-back' ensures the health provider checks for understanding with patients and then allowing opportunity for clarification. This study hypothesises that there is a poor baseline understanding amongst patients living with CHB and that the teach-back method will improve disease-specific knowledge. This would form the foundation for future studies to evaluate how improved understanding translates into greater health outcomes.

Interventions

Participants in the intervention group received a once-off education session prior to their routine liver clinic outpatient appointment, run by a trained investigator, using the teach-back strategy. This session involved a discussion between the investigator and participant on the four domains of CHB – transmission, natural history, epidemiology and prevention and clinical management; supported by simple explanations and images using an educational resource specifically developed for people with

Participants in the intervention group received a once-off education session prior to their routine liver clinic outpatient appointment, run by a trained investigator, using the teach-back strategy. This session involved a discussion between the investigator and participant on the four domains of CHB – transmission, natural history, epidemiology and prevention and clinical management; supported by simple explanations and images using an educational resource specifically developed for people with low health literacy. This session continued until the participant had adequate understanding of each aspect covered, which ranged from 15-45 minutes. Information was explained using plain language and medical jargon avoided. After covering each concept, the investigator would use teach-back to confirm patient understanding, for example: ‘To check that I have explained the information clearly, could you please tell me how hepatitis B is spread?’. If the answers were wrong or incomplete, the investigator would re-explain the concept and reassess until the participant understood the information. The trained investigator was a final year medical student, who had received training to facilitate the 'teach-back' intervention from the viral hepatitis nurse.

Sponsors

Alexander Thompson
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

English-speaking patients aged 18 years or greater and diagnosed with chronic hepatitis B were eligible for the study

Exclusion criteria

Subjects will be excluded from the study for the following criteria: 1. Decompensated liver disease 2. Unwilling / unable to participate in a questionnaire 3. Non-English speaking patients 4. Withdraws from study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026